The phenotypic and genetic heterogeneity of autism spectrum disorder (ASD) presents considerable challenges in understanding etiological pathways, selecting effective therapies, providing genetic counselling, and predicting clinical outcomes. With advances in genetic and biological research alongside rapid-pace technological innovations, there is an increasing imperative to access large, representative, and diverse cohorts to advance knowledge of ASD. To date, there has not been any single collective effort towards a similar resource in Australia, which has its own unique ethnic and cultural diversity. The Australian Autism Biobank was initiated by the Cooperative Research Centre for Living with Autism (Autism CRC) to establish a large-scale repository of biological samples and detailed clinical information about children diagnosed with ASD to facilitate future discovery research.
The primary group of participants were children with a confirmed diagnosis of ASD, aged between 2 and 17 years, recruited through four sites in Australia. No exclusion criteria regarding language level, cognitive ability, or comorbid conditions were applied to ensure a representative cohort was recruited. Both biological parents and siblings were invited to participate, along with children without a diagnosis of ASD, and children who had been queried for an ASD diagnosis but did not meet diagnostic criteria. All children completed cognitive assessments, with probands and parents completing additional assessments measuring ASD symptomatology. Parents completed questionnaires about their child’s medical history and early development. Physical measurements and biological samples (blood, stool, urine, and hair) were collected from children, and physical measurements and blood samples were collected from parents. Samples were sent to a central processing site and placed into long-term storage.
The establishment of this biobank is a valuable international resource incorporating detailed clinical and biological information that will help accelerate the pace of ASD discovery research. Recruitment into this study has also supported the feasibility of large-scale biological sample collection in children diagnosed with ASD with comprehensive phenotyping across a wide range of ages, intellectual abilities, and levels of adaptive functioning. This biological and clinical resource will be open to data access requests from national and international researchers to support future discovery research that will benefit the autistic community.
APA. Diagnostic and statistical manual of mental disorders (DSM-5®). Washington: American Psychiatric Pub; 2013.
CDC. Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. MMWR Surveill Summ. ERIC; 2014;63.
Chen M-H, Su T-P, Chen Y-S, Hsu J-W, Huang K-L, Chang W-H, et al. Comorbidity of allergic and autoimmune diseases in patients with autism spectrum disorder: a nationwide population-based study. Res Autism Spectr Disord. 2013;7:205–12. CrossRef
Doshi-Velez F, Ge Y, Kohane I. Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis. Pediatrics Am Acad Pediatrics. 2014;133:e54–63.
Polyak A, Kubina RM, Girirajan S. Comorbidity of intellectual disability confounds ascertainment of autism: implications for genetic diagnosis. Am J Med Genet Part B Neuropsychiatr Genet. 2015;168:600–8. CrossRef
Brown WT, Friedman E, Jenkins EC, Brooks J, Wisniewski K, Raguthu S, et al. Association of fragile X syndrome with autism. Lancet. 1982;319:100. CrossRef
Consortium SVIP. Simons variation in individuals project (Simons VIP): a genetics-first approach to studying autism spectrum and related neurodevelopmental disorders. Neuron. 2012;73:1063–7. CrossRef
Loth E, Charman T, Mason L, Tillmann J, Jones EJH, Wooldridge C, et al. The EU-AIMS longitudinal European autism project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders. Mol. Autism. 2017;8:24.
Yuen RKC, Merico D, Bookman M, Howe JL, Thiruvahindrapuram B, Patel RV, et al. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat. Neurosci. 2017;20:602–11.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). American Psychiatric Pub; 2000.
Lord C, Rutter M, DiLavore P C, Risi S, Gotham K, Bishop S. Autism Diagnostic Observation Schedule Second Edition. Torrance: Western Psychological Services; 2012.
Mullen EM. Mullen scales of early learning. MN: AGS Circle Pines; 1995.
Wechsler D. Wechsler intelligence scale for children–fourth edition (WISC-IV). San Antonio: TX Psychol. Corp; 2003.
Sparrow SS, Cicchetti DV, Balla DA. Vineland adaptive behavior scales: (Vineland II), survey interview form/caregiver rating form. Livonia: MN Pearson Assessments; 2005.
Dunn W. Sensory profile 2: User’s manual. Psych Corporation; 2014.
Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child BMJ Publishing Group Ltd. 1970;45:13–23. CrossRef
Constantino JN, Gruber CP. Social responsiveness scale (SRS) - 2nd edition. California: WPS; 2012.
Wechsler D, Hsiao-pin C. WASI-II: Wechsler abbreviated scale of intelligence. Pearson; 2011.
Whitehouse AJO, Bishop DVM. Communication checklist—adult. London: The Psychological Corporation / A Harcourt Assessment Company; 2009.
Bishop DVM. The Children’s communication checklist: CCC-2. ASHA; 2003.
- Study protocol for the Australian autism biobank: an international resource to advance autism discovery research
Gail A. Alvares
Paul A. Dawson
Naomi R. Wray
Andrew J. O. Whitehouse
the Australian Autism Biobank team
- BioMed Central
Neu im Fachgebiet Pädiatrie
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II